Discover open access scientific publications

Search, annotate, share and cite publications

Publications by R B Cohen

Phase 1 Trial of the Antiangiogenic Peptide ATN-161 (Ac-PHSCN-Nh2), a Beta Integrin Antagonist, in Patients With Solid Tumours

British Journal of Cancer

Cancer Research

English

Related publications

Correction: A Phase I Trial of LY2510924, a CXCR4 Peptide Antagonist, in Patients With Advanced Cancer

Clinical Cancer Research

Cancer Research

English

A Phase I Study of the HDM2 Antagonist SAR405838 Combined With the MEK Inhibitor Pimasertib in Patients With Advanced Solid Tumours

British Journal of Cancer

Cancer Research

English

Trial of an Aromatic Retinoid in Patients With Solid Tumours

British Journal of Cancer

Cancer Research

English

A Phase I Trial of Ispinesib, a Kinesin Spindle Protein Inhibitor, With Docetaxel in Patients With Advanced Solid Tumours

British Journal of Cancer

Cancer Research

English

Clinical Trial With a Beta-Receptor Antagonist (Propranolol) in Parkinsonism.

Journal of Neurology, Neurosurgery and Psychiatry

English

Phase I Study of TAS-102 Treatment in Japanese Patients With Advanced Solid Tumours

British Journal of Cancer

Cancer Research

English

A Phase I Study of E7080, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Tumours

British Journal of Cancer

Cancer Research

English

Phase 1 Study of the MDM2 Antagonist RO6839921 in Patients With Acute Myeloid Leukemia

Investigational New Drugs

English

Targeting Hypoxia-Inducible Factor-1α (HIF-1α) in Combination With Antiangiogenic Therapy: A Phase I Trial of Bortezomib Plus Bevacizumab

English